Ginsenoside Rg5 relieves type 2 diabetes by improving hepatic insulin resistance in db/db mice
Type 2 diabetes mellitus (T2DM) is a systemic metabolic disorder that has become a major threat to public health. Ginsenoside Rg5 (Rg5) has a putative hypoglycemic effect, but its potential mechanism remains unclear. Here, we found that Rg5 not only reduced glycolipid parameters (FBG, TC, TG, and LD...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-08-01
|
| Series: | Journal of Functional Foods |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464620302383 |